ANALISIS KOMBINASI PENGGUNAAN OBAT PADA PASIEN JANTUNG KORONER DI RUMAH SAKIT UNIVERSITAS HASANUDDIN MAKASSAR
Keywords:
Penyakit jantung koroner, profil pengobatan, kombinasi obatAbstract
Penyakit jantung koroner (PJK) merupakan penyebab kematian utama di dunia, sementara dislipidemia merupakan faktor risiko tersering dari penyakit jantung koroner. Penelitian ini bertujuan untuk mengetahui analisis kombinasi obat serta profil pengobatan yang digunakan pada pasien jantung koroner di RS Universitas Hasanuddin Makassar. Jenis penelitian ini adalah penelitian observasional dengan menggunakan metode cross sectional yang bersifat deskriptif. Pengumpulan data dilakukan pada bulan Maret 2021-Mei 2021 di RS Universitas Hasanuddin Makassar. Hasil penelitian berdasarkan karakteristik pasien PJK menunjukkan jumlah pasien laki-laki lebih banyak dibandingkan perempuan yaitu sebesar 76 pasien (58,5%), jumlah pasien terbanyak pada kelompok usia 61-80 tahun sebesar 73 pasien (56,2%), dan pasien dilihat dari lama hari rawatnya 1-7 hari sebanyak 107 pasien (82,3%). Penyakit dislipidemia merupakan penyakit penyerta terbanyak yang ditemukan pada 109 pasien (83,3%). Kombinasi obat yang paling sering diberikan pada pasien jantung koroner yaitu antihipertensi, antitrombotik, penurun kolesterol (40,76%), serta ditemukan beberapa obat yang berinteraksi secara farmakodinamik.
References
PERKI. Indonesian Heart Association. Jilid 1, Jakarta: JurnaL Kardiologi Indonesia. 2019: 29.
World Health Organization (WHO). Commission on Ending Childhood Obesity. Geneva, World Health Organization, Department of Non communicable disease surveillance. 2014.
Riset Kesehatan Dasar (Riskesdas). Badan Penelitian dan Pengembangan Kesehatan Kementerian RI tahun 2018. https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasar-riskesdas/
Ferrari, R, Fox, K. Heart rate reduction in coronary artery disease and heart failure. Nat. Rev. Cardiol. 2016. 13(8):493-501. Doi: 10.1038/nrcardio.2016.84.
Waradhika, R. Kajian Interaksi Obat Pada Pasien Penyakit Jantung Koroner di Instalasi Rawat Inap Rumah Sakit Panti Rapih Yogyakarta Periode 2005. Fakultas Farmasi Universitas Sanata Dharma, Yogyakarta. 2015.
Yahya, A.F. Menaklukkan Pembunuh no.1 : Mencegah dan Mengatasi Penyakit Jantung Koroner Secara Tepat. PT Mizan Pustaka, Bandung. 2010.
Abidin, Z. Faktor Resiko Penyakit Jantung Koroner Pada pasien Rawat Inap di Cardiovascular Care Unit (CVCU) Cardiac Centre RSUP Dr Wahidin Sudirohusodo Makassar. Periode Januari-Juli 2008.
Tan, N.C., Koh, E.Y.L., Goh, C.C., Goh, P.S.C., and Koh, K.H. A. Cross Sectional Study of Gender Differences in Lifestyle Behavior and Usage of Medications among Community-Dwelling Asians Towards Achieving Their LDL Cholesterol Treatment Goals. Proceedings Of Singapore Healthcare. 2017. 26(3): 158-165 https://Doi.org/10.1177/2010105817694906
Shuhalili MFRMA, Samsudin IN, Stanslas J, Hasan S, Thambiah SC. Effect of different types of statin on lipid profile: A perspective on asians. Int J Endocrinol Metab. 2017. 15(2) PMCID: PMC5556327. DOI: 10.5812/ijem.43319
Wells, B. et al. Pharmacotherapy Handbook. Ninth Edit. McGraw Hill Education: New York. 2015: 65-74
Leung AA, Daskalopoulou SS, Dasgupta K, et al; Hypertension Canada. Hypertension Canada’s. Guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017 May;33(5):557-576. Doi: 10.1016/j.cjca.2017.03.005.
American Diabetes Association (ADA). Standard of Medical Care in Diabetes 2016. USA: American Diabetes Association. 2016.
Marzilli, M.; Merz, C.N.; Boden, W.E.; Bonow, R.O.; Capozza, P.G.; Chilian, W.M.; DeMaria, A.N.; Guarini, G.; Huqi, A.; Morrone, D. Obstructive Coronary Atherosclerosis and Ischemic Heart Disease: An Elusive Link! J. Am. Coll. Cardiol. 2012: 60, 951–956. Doi: 10.1016/j.jacc.2012.02.082.
Dezsi, C. A., & Szentes, V. The Real Role of β-Blockers in Daily Cardiovascular Therapy. American Journal of Cardiovascular Drugs. 2017: 361–373. Doi: 10.1007/s40256-017-0221-8.
Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, et al. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials. Cardiovasc. 2020 Apr 23. 3987065. Doi: 10.1155/2020/3987065.
Suzanne V. Arnold, Deepak L. Bhatt, Gregory W. Barsness, Alexis L. Beatty, Mikhail Kosiborod, Lawrence A. Leiter. Clinical Management of Stable Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus. A Scientific Statement from the American Heart Association. Originally published13 Apr 2020. https://doi.org/10.1161/CIR.0000000000000766
Baxter & Predson. Stockley’s Drug Interaction. Tenth Edition. Pharmaceutical Press, Great Britain. 2013
Cerner, M. I. Drug Interaction Classification. Retrieved. 2013.
Stockley H.I. DrugInteraction. London: Blackwell Science Ltd. 2008.
Tatro, D. S. Drug Interaction Fact. USA.: A Walter Kluwer Health. USA. 2001.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Majalah Farmasi dan Farmakologi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copyright to this article is transferred to Universitas Hasanuddin (UNHAS) if and when the article is accepted for publication. The undersigned hereby transfers all rights in and to the paper including without limitation all copyrights to UNHAS. The undersigned hereby represents and warrants that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required. The undersigned represents that he/she has the power and authority to make and execute this assignment.
We declare that:
- This paper has not been published in the same form elsewhere.
- It will not be submitted anywhere else for publication prior to acceptance/rejection by this Journal.
- A copyright permission is obtained for materials published elsewhere and which require this permission for reproduction.
Furthermore, I/We hereby transfer the unlimited rights of publication of the above-mentioned paper in whole to UNHAS The copyright transfer covers the exclusive right to reproduce and distribute the article, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.
The corresponding author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. This agreement is to be signed by at least one of the authors who have obtained the assent of the co-author(s) where applicable. After submission of this agreement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted.
